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 Abstract
The transient increase of the cytoplasmic free calcium level in T lymphocytes plays a
key role in initiating and maintaining the autoimmune reaction in rheumatoid arthritis
(RA). Kv1.3 and IKCa1 potassium channels are important regulators of the mainte-
nance of calcium influx during lymphocyte activation and present a possible target for
selective immunomodulation. We aimed to compare peripheral T lymphocyte calcium
influx kinetics upon activation in patients with recently diagnosed and established RA,
and to demonstrate the differences in analysis of kinetic flow cytometry data when
using two different algorithms. We took peripheral blood samples from nine patients
with recently diagnosed and six patients with established RA. We evaluated calcium
influx kinetics following activation in CD4, Th1, Th2, and CD8 cells applying an
approach based on smoothing of median fluorescence values (FlowJo) and an algorithm
based on function fitting (FacsKin). We assessed the sensitivity of the above subsets to
specific inhibition of the Kv1.3 and IKCa1 potassium channels. Th2 cells of patients
with established RA react slower to activating stimuli, whereas CD8 cells show a faster
reaction than in patients with recently diagnosed RA. While initially Th1 cells are less
sensitive to the inhibition of Kv1.3 and IKCa1 channels in RA, their sensitivity increases
along with the duration of the disease. With the algorithm of function fitting instead of
smoothing, more statistically significant differences of potassium channel inhibition
between the two RA groups could be demonstrated. The function fitting algorithm
applied by FacsKin is suitable to provide a common basis for evaluating and comparing
flow cytometry kinetic data. ' 2013 International Society for Advancement of Cytometry
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The short-term activation of T lymphocytes, especially that of autoreactive T cells,
plays a key role in initiating and maintaining most autoimmune reactions, including
that observed in rheumatoid arthritis (RA). The transient increase of the cytoplasmic
free calcium level ([Ca21]cyt) in T lymphocytes is an indispensable part of this pro-
cess. The engagement of the TCR/CD3 complex upon antigen presentation leads to
the activation of several transmembrane signaling pathways which result in Ca21
release from intracellular stores. This is followed by further Ca21 entry from the
extracellular space through the store-operated calcium release activated calcium
(CRAC) channels. Voltage-gated Kv1.3 and calcium-dependent IKCa1 K1 channels
play a pivotal role in the maintenance of [Ca21]cyt, since they sustain the electroche-
mical potential gradient needed for further Ca21 entry by the efflux of K1 from the
cytoplasm (1,2). Specific inhibition of these channels results in diminished Ca21
influx and a lower level of lymphocyte activation and proliferation (3,4).
This observation offers a unique opportunity for targeted pharmacological
intervention with improved specificity from existing drugs against disease-causing
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autoreactive lymphocytes. According to Beeton et al., disease-
associated autoreactive T cells are mainly CCR72 CD45RA2
effector memory T cells (TEM cells) with elevated Kv1.3 chan-
nel expression, in comparison with naive and central memory
T cells (TCM cells) that express low levels of Kv1.3 channels.
Consequently, Kv1.3 inhibitors primarily suppress the activa-
tion and proliferation of the autoantigen-specific TEM cells,
while sparing other classes of T cells (5). Beeton et al. also
evaluated the therapeutic effects of Kv1.3 inhibitors in a rat
model of RA. The animals treated with the specific Kv1.3
channel blockers showed significantly less joint deviations and
significant improvement in radiological and histopathological
findings (6). In addition, no clinical side-effects or signs of
toxicity were identified during the trial. However, our earlier
trial on human samples from patients with RA showed that
Th2 and particularly CD8 cells are inhibited more dominantly
than Th1 and CD4 cells. Thus the inhibition of Kv1.3 channels
does not seem to be specific enough in peripheral human RA
lymphocytes, since anti-inflammatory Th2 cells are also
affected to a noteworthy extent (7).
Flow cytometry is a suitable method for the sequential
determination of [Ca21]cyt in millions of stimulated lympho-
cytes over a time period. It also enables the comparison of
Ca21 influx kinetics in more than one lymphocyte subsets of
the same sample simultaneously. However, until recently, there
had been an unmet need for a method that can reliably com-
pare kinetic flow cytometry data. A number of approaches have
been available as part of various flow cytometry software for
characterizing kinetic measurements. These approaches calcu-
late median fluorescence of the dye of interest and apply a
smoothing method in order to describe given parameters of the
recording, such as the area under the curve (AUC) value (8).
Our research group developed a robust algorithm (Fac-
sKin) that fits functions to median values of the data of inter-
est and calculates relevant parameters describing each
function. By selecting the best fitting function, this approach
provides an opportunity for the mathematical analysis and
statistical comparison of kinetic flow cytometry measurements
of distinct samples (9).
In this study, we used flow cytometry to characterize
Ca21 influx kinetics upon activation in major T cell subsets
(CD4, Th1, Th2, CD8) isolated from patients with recently
diagnosed and established RA and their sensitivity to the spe-
cific inhibition of Kv1.3 and IKCa1 lymphocyte K1 channels.
For the evaluation of kinetic flow cytometry data, we utilized
FacsKin, our novel algorithm (9), and the kinetic module of
FlowJo, a currently available flow cytometry software. We
hypothesized that FacsKin enables the discovery of more dif-
ferences between Ca21 influx kinetics of the investigated RA
groups and provides a more precise characterization of kinetic
measurements than currently available methods.
MATERIALS AND METHODS
Sample Collection
Peripheral blood samples were drawn from nine patients
with recently diagnosed RA who had not received anti-
rheumatic treatment, including non-steroidal anti-inflamma-
tory drugs (NSAIDs), disease modifying anti-rheumatic drugs
(DMARDs), and glucocorticoids until the time of blood sam-
pling, as well as from six patients with established RA who had
been treated with methotrexate monotherapy and low dose
methyl-prednisolone for years. Clinical parameters of study
participants are summarized in Table 1. Patients with RA were
diagnosed according to the latest ACR/EULAR criteria (10).
No co-morbidities were detected in patients based on routine
laboratory investigations and physical examination that could
have influenced our investigation. Written informed consent
was obtained from all subjects, and our study was reviewed
and approved by an independent ethical committee of the uni-
versity. Laboratory studies and interpretations were performed
on coded samples lacking personal and diagnostic identifiers.
The study was adhered to the tenets of the most recent revi-
sion of the Declaration of Helsinki.
Sample Preparation
Peripheral blood mononuclear cells (PBMCs) were iso-
lated by a standard density gradient centrifugation (Ficoll
Paque, Amersham Biosciences AB, Uppsala, Sweden, 25 min,
400g, room temperature) from 9 ml of freshly drawn periph-
eral venous blood collected in lithium heparin treated tubes
(BD Vacutainer, BD Biosciences, San Jose, CA). The cell sus-
pension was washed twice in phosphate buffered saline. Cells
were kept in a modified RPMI medium (Sigma-Aldrich, St.
Louis, MO) throughout the following steps of the procedure.
The Ca21 concentration of this medium was set to 2 mM by
the addition of crystalline CaCl2.
PBMCs were divided into three vials with equal cell num-
bers and one extra vial for the assessment of Kv1.3 channel
expression. In order to differentiate T lymphocyte subsets,
PBMCs were incubated with the following conjugated anti-
human monoclonal antibodies for 30 min in dark at room
temperature according to the manufacturer’s instructions (all
from BD Pharmingen, San Diego, CA): anti-CD4 PE-Cy7
(clone SK3), anti-CD8 APC-Cy7 (clone SK1), anti-CXCR3
APC (clone 1C6/CXCR3), and anti-CCR4 PE (clone 1G1).
The extra vial was in addition incubated with anti-Kv1.3
Table 1. Clinical characteristics of study participants
CHARACTERISTICS
RECENTLY DIAGNOSED
RA PATIENTS, N 5 9
RA PATIENTS WITH
ESTABLISHED
DISEASE, N5 6
Age (years) 58 [44–61] 61 [59–72]
Gender (male/
female)
4/5 2/4
RA duration 3 [2–4.5] months 7.5a [5–9.5] years
CRP (mg/L) 30.6 [16.1–63.0] 7.4a [5.7–17.8]
ESR (mm/h) 50 [44–74] 20a [16–37]
Data are expressed as median [interquartile range] for con-
tinuous variables and as number for categorical variables.
CRP, C reactive protein; ESR, erythrocyte sedimentation rate,
RA, rheumatoid arthritis.
a P\0.05 vs. patients with recently diagnosed RA.
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channel FITC (Sigma-Aldrich). After washing, PBMCs were
loaded with Ca21 sensitive Fluo-3 and Fura Red dyes supple-
mented with Pluronic F-127 for 20 min in dark at 308C
according to the manufacturer’s recommendations (Invi-
trogen, Carlsbad, CA). Cells were washed once before mea-
surement and kept at 308C in dark until measurement.
One vial was used as control. Another vial was treated
with margatoxin (MGTX, 60 nM), a selective blocker of the
Kv1.3 channel (Sigma-Aldrich) for 15 min before measure-
ment. The third vial was treated with a triarylmethane com-
pound, TRAM-34 (60 nM), a specific inhibitor of the IKCa1
channel (Sigma-Aldrich) for 10 min before measurement.
PBMCs were activated by the addition of 20 lg phytohemag-
glutinin (PHA) and recording was initiated directly afterwards.
Flow Cytometric Analysis
Flow cytometry measurements were conducted on a BD
FACSAria flow cytometer (BD Biosciences) and data were pro-
cessed using the FACSDiva software (v 6.0). The original
instrument settings have not been altered regarding flow cell
(fixed-alignment cuvette flow cell) and fluidics, light sources,
excitation optics, optical filters, detectors, and paths.
Cell-bound fluorescent labels were excited with a 488-nm
Coherent Sapphire solid state (14 mW) and a 633-nm JDS Uni-
phase HeNe air-cooled (14 mW) laser. PE fluorescence was
detected through a 575/26 nm BP filter, PE-Cy7 fluorescence
through a 780/60 nm BP filter, APC fluorescence through a
660/20 nm BP filter, APC-Cy7 fluorescence through a 780/60
nm BP filter, Fluo-3 and FITC fluorescence through a 530/30
nm BP filter, and Fura Red fluorescence through a 695/40 nm
BP filter. The fluorescence signal data were recorded with loga-
rithmical amplification. Compensation was performed compu-
tationally post acquisition, based on single stained control set-
tings. The flow cytometer was set up before experiments using
seven-color beads (BD FACS, BD Biosciences). Cell fluores-
cence data were measured and recorded for 10 min in a kinetic
manner (average cell acquisition rate was 1,000 cells per sec).
Lymphocytes were separated from PBMCs and cell debris
by setting a polygonal gate in the forward scatter (FSC)/side
scatter (SSC) plot. CD4 and CD8 lymphocytes were identified
and selected in the CD4/CD8 plot by their CD4 positivity and
lack of CD8 expression, as well as by their CD8 positivity and
lack of CD4 expression, respectively. CD4 cells were further
analyzed in a CXCR3/CCR4 plot. Th1 lymphocytes were
regarded as CD41 CXCR31 CCR4-cells, while Th2 lympho-
cytes were regarded as CD41 CXCR32 CCR41 cells.
[Ca21]cyt was calculated based on a fix ratio of Fluo-3 and
Fura Red dyes (25%) after gating of the individual lymphocyte
subsets plotted against time (Fig. 1A).
For evaluation of the acquired kinetic data, we compared
FacsKin (v 0.5.16, Fig. 1B), a specific software developed at
our laboratory (available at www.facskin.com along with a
detailed description of the evaluation process) as well as the
kinetic module of FlowJo (v 7.6.3, Fig. 1C). Analysis with Fac-
sKin is based on the calculation of a double-logistic function
for each Ca21 influx recording. This function is used to
characterize measurements that have an increasing and a
decreasing intensity as time passes. The software calculates pa-
rameter values describing each function, such as the AUC,
Maximum (Max), Time to reach maximum (tmax), and Slope
values (Fig. 2). The AUC value describes the full amount of
[Ca21]cyt during the whole recorded period of Ca
21 influx
Figure 1. A: The ratio of Fluo-3 and Fura Red dyes after gating of
the individual lymphocyte subsets plotted against time. B: Double-
logistic function representing Ca21 influx kinetics calculated by
FacsKin. C: Ca21 influx kinetics calculated by FlowJo based on me-
dian fluorescence data and smoothing. [Color figure can be viewed
in the online issuewhich is available at wileyonlinelibrary.com]
Figure 2. Parameter values describing each function calculated
by FacsKin. AUC, area under the curve; Max, Maximum; tmax,
Time to reach maximum. [Color figure can be viewed in the online
issue which is available at wileyonlinelibrary.com]
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and thus corresponds to the sum of [Ca21]cyt increase, which
is consistent with the level of lymphocyte activation (1). One
unit (U) of the AUC value is defined as one relative intensity
value in 1 sec, where relative intensity values are the rate of
actual intensity values divided by intensity values at zero sec-
ond. The Maximum value represents the peak of the Ca21
influx curve upon lymphocyte activation, thus it reflects the
maximal amount of [Ca21]cyt along the course of activation.
The Time to reach maximum value represents how soon the
Max value is reached. The Slope value reflects how rapidly the
peak of Ca21 influx is reached (7,11,12). Since AUC is
regarded as the best single parameter describing the magni-
tude of Ca21 influx, this parameter was also calculated using
the kinetic module of FlowJo (v 7.6.3).
Statistical Analysis
Data are expressed as median and interquartile range.
Comparisons between the two patient groups were made with
Mann–Whitney tests. Comparisons between paired values
(samples with or without treatment with specific K1 channel
blockers) in the same patient were made with Wilcoxon tests.
P values less than 0.05 were considered significant. The study
was not powered for the multitude of statistical tests per-
formed, thus some significances could occur by chance alone.
Statistics were calculated using GraphPad Prism v 5.0
(GraphPad Software, San Diego, CA).
RESULTS
Clinical Data
The age and gender distribution of participants were sim-
ilar in both RA study groups. Inflammatory parameters (C re-
active protein values and erythrocyte sedimentation rate) were
higher in patients with recently diagnosed RA than in patients
suffering from established RA (Table 1).
Lymphocyte Calcium Influx Kinetics Evaluated with
FacsKin
The calculated parameter values (AUC, Max, tmax, and
Slope) were compared upon lymphocyte activation between
patients with recently diagnosed RA and established RA. The
parameters are shown in Supporting Information Table 1.
Slope values showed no alteration between the study groups in
the investigated lymphocyte subsets, and therefore are not
included in the table. In the Th2 subset, the tmax value of Ca
21
influx was elevated in patients with established RA compared
to patients with recently diagnosed RA. Meanwhile, we regis-
tered a significantly lower tmax value within the CD8 subset in
patients with established RA than in patients with recently
diagnosed RA. We found no difference in the parameters of
calcium influx in the CD4 and Th1 subsets. tmax values were
higher in lymphocytes isolated from patients with RA and are
reached more rapidly in the CD41 subsets compared to
healthy controls.
The Effects of K1 Channel Inhibitors on Lymphocyte
Calcium Influx Evaluated with FacsKin
We evaluated the effects of specific inhibitors of the Kv1.3
and IKCa1 channels (MGTX and TRAM, respectively) on pa-
rameter values of Ca21 influx in both RA study groups.
Results are shown in Figure 3 and Supporting Information
Table 1. Slope values showed no alteration in the investigated
lymphocyte subsets upon inhibitor treatment, and therefore
are not included in the table. In healthy individuals, the
Figure 3. Analysis of results using FacsKin. Box-plots representing the effects of MGTX and triarylmethane (TRAM) application on AUC
values of Ca21 influx kinetics in lymphocytes obtained from nine patients with recently diagnosed RA and six RA patients with established
disease. Horizontal linemedian, box interquartile range, whiskers range. RA, rheumatoid arthritis. dMGTX and TRAM treated sam-
ples were compared with samples with no inhibitor application within lymphocytes isolated from patients with recently diagnosed RA, P
\ 0.05, eMGTX and TRAM treated samples were compared with samples with no inhibitor application within lymphocytes isolated from
patients with RA with established disease, P\0.05.
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inhibition of the IKCa1 channel decreased calcium influx in
Th2 and CD4 cells to a lower extent than in Th1 and CD8
cells. The AUC value was decreased by both MGTX and
TRAM in all subsets in both RA study groups. Both MGTX
and TRAM decreased the Max value in all subsets of patients
with recently diagnosed RA, but only in the Th1 subset in
patients with established RA. The tmax value was only
decreased by TRAM in the CD8 subset of patients with
recently diagnosed RA. On the contrary, the tmax value of the
CD8 subset in samples isolated from patients with established
RA showed an increasing tendency upon TRAM treatment.
The extent of the alterations in parameter values was charac-
teristic for the investigated study groups and the inhibited K1
channels in each subset, as detailed in the Discussion.
Lymphocyte Calcium Influx Kinetics Evaluated with
FlowJo
Since the AUC value is considered to be the most repre-
sentative single value for Ca21 influx characteristics, AUC
values were compared upon lymphocyte activation between
patients with recently diagnosed RA and patients with estab-
lished RA using the kinetic module of FlowJo (Supporting In-
formation Table 2). No differences were detected between the
two study groups in AUC values.
The Effects of K1 Channel Inhibitors on Lymphocyte
Calcium Influx Evaluated with FlowJo
We also evaluated the effects of specific Kv1.3 and IKCa1
channel inhibitors (MGTX and TRAM, respectively) on AUC
values of lymphocyte Ca21 influx in both RA study groups
using FlowJo. Results are presented in Figure 4 and Supporting
Information Table 2. AUC values were decreased by MGTX in
the CD4 and Th2 subsets of patients with recently diagnosed
RA. Upon TRAM treatment, the CD4, Th1, and Th2 subsets
of patients with recently diagnosed RA showed a decrease in
AUC values. Neither TRAM nor MGTX treatment had a de-
tectable effect on lymphocyte Ca21 influx of patients with
established RA.
Kv1.3 Channel Expression in the Investigated
Lymphocyte Subsets
We compared the median fluorescence intensity of the
antibody against Kv1.3 channels in all investigated lymphocyte
subsets between the two study groups. No significant differ-
ence could be observed in the median fluorescence intensity
values (Table 2).
DISCUSSION
In our investigation, we aimed to compare peripheral T
lymphocyte Ca21 influx kinetics upon activation in two differ-
ent subgroups of RA, and to demonstrate the differences in
analysis of kinetic flow cytometry data when using two differ-
ent algorithms.
After analyzing data with FacsKin, significant differences
could be observed in Ca21 influx kinetics between patients
with recently diagnosed RA and patients with established RA
(Supporting Information Table 1). Our results revealed that
the tmax value of the Th2 subset in patients with established
RA is reached slower compared to patients with recently diag-
nosed RA, indicating that Th2 cells respond slower to activat-
ing stimuli as the disease duration increases. Th2 cells mainly
regulate anti-inflammatory responses, thus this finding possi-
bly indicates the remission of immunoregulatory process
along with the duration of the disease. This is in contrast with
our earlier findings in RA, which presented an elevated Th2
response in the early stages of RA compared to healthy con-
trols (Supporting Information Table 1) (7), presumably to
control the ongoing inflammation. On the contrary, we meas-
ured lower tmax values in the CD8 subset of patients with
established RA, which may indicate an enhanced direct cyto-
toxic response, raising the notion that the increasing duration
of the disease results in an even greater imbalance between the
pro- and anti-inflammatory responses. The peak of calcium
influx in lymphocytes isolated from patients with RA is
reached more rapidly in the CD41 subsets compared to
healthy individuals, indicating that they respond more quickly
to stimulation, probably due to the ongoing autoimmune
response.
Upon treatment with specific inhibitors of the Kv1.3 and
IKCa1 channels (MGTX and TRAM, respectively), AUC values
decreased in all subsets in both RA study groups. However, the
sensitivity of the two study groups was different to lymphocyte
K1 channel inhibition. Blocking the Kv1.3 channel decreased
Ca21 influx in the CD4, Th2, and CD8 subsets of patients
with established RA to a lower extent than in patients with
recently diagnosed RA. However, Th1 cells were more sensitive
to the inhibition of Kv1.3 channels in patients with established
RA. In patients with recently diagnosed RA, Max values
decreased in all subsets upon treatment with MGTX, while in
patients with established RA, the Max value decreased in the
Th1 subset only. Similarly, upon the inhibition of the IKCa1
channel, Th1 cells of patients with established RA showed a
higher level of decrease of the AUC and Max values than those
of patients with recently diagnosed RA.
The above results could either be due to the altered
expression or different functionality of Kv1.3 channels. There-
fore, we measured the cell surface expression of these channels
on the investigated lymphocyte subsets in a semi-quantitative
manner using a specific antibody. However, we could not
detect a difference in the expression of Kv1.3 channels between
Table 2. Median fluorescence values of the anti-Kv1.3 FITC anti-
body in lymphocytes isolated from 9 recently diagnosed RA
patients and 6 RA patients with established disease
RECENTLY DIAGNOSED
RA PATIENTS, N5 9
RA PATIENTS WITH
ESTABLISHED DISEASE,
N5 6
CD4 54 [39–64] 63 [21–99]
Th1 53 [36–69] 31 [14–58]
Th2 47 [27–95] 25 [10–53]
CD8 63 [19–93] 32 [13–50]
Data are expressed as median [interquartile range].
RA, rheumatoid arthritis.
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the two study groups. Hence, we presume that functional
alterations are responsible for the altered sensitivity to Kv1.3
channel inhibition in patients with established RA. Of note,
due to the lack of commercially available antibodies against
IKCa1, we could not investigate its expression in a similar
manner.
Our findings indicate that while initially Th1 cells are less
sensitive to the inhibition of Kv1.3 and IKCa1 channels in RA,
their sensitivity increases along with the duration of the dis-
ease. Based on our results, it is difficult to tell whether this dif-
ference is due to the primary course of the disease or whether
it is influenced by pharmacological treatment.
We also compared the AUC values, the most representa-
tive parameter for kinetic measurements, using the kinetic
module of FlowJo (Supporting Information Table 2). How-
ever, the above difference between the sensitivity of recently
diagnosed and established RA lymphocytes to K1 channel in-
hibition could not be demonstrated based on results obtained
with this approach. In fact, we could not observe any effect of
the applied inhibitors in the established RA group when data
were analyzed with FlowJo. A plausible explanation for this
might be that FlowJo is based on a smoothing method of me-
dian fluorescence values performed by moving average calcu-
lation. However, due to the non-normal distribution of flow
cytometry data (13), techniques that assume normality (such
as those calculating average or standard deviation) lead to
potentially incorrect smoothing and artifacts in the kinetic pa-
rameter (8).
With our method of function fitting and selecting the
best fitting function for the kinetics of the studied biological
mechanism instead of smoothing, more statistically significant
differences of K1 channel inhibition between the recently
diagnosed and established RA groups could be demonstrated.
The use of our algorithm largely improves the evaluation
of kinetic flow cytometry compared to the current, non-
standardized approaches that largely depend on the observers’
personal experience, revealing more detailed information and
delicate differences of the investigated kinetic process (8,9).
A limitation of our study is the use of cell surface che-
mokine receptors instead of intracellular cytokine staining
for the identification of Th1 and Th2 cells. The option to
use intracellular cytokines as markers of the T helper sub-
sets in our current experiment had to be excluded, since
permeabilization of the cell membrane to stain intracellular
cytokines would have prevented us from studying calcium
influx. However, literary data and our experience indicate
that the applied cell surface chemokine receptor markers are
sufficient for the identification of the investigated T helper
subsets (14,15).
In conclusion, following evaluation with FacsKin, we
were able to describe numerous differences in Ca21 influx
kinetics of major peripheral blood T lymphocyte subsets of
patients with recently diagnosed RA and patients with estab-
lished RA which could not be detected using currently avail-
able approaches employing smoothing methods. We found
that Th2 cells of patients with established RA react slower to
activating stimuli, whereas CD8 cells show a faster reaction
than in patients with recently diagnosed RA. While initially
Th1 cells are less sensitive to the inhibition of Kv1.3 and
IKCa1 channels in RA, their sensitivity increases along with
the duration of the disease. These data demonstrate that the
function fitting algorithm of FacsKin is suitable to provide a
common basis for evaluating and comparing flow cytometry
kinetic data.
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Figure 4. Analysis of results using FlowJo. Box-plots representing the effects of MGTX and triarylmethane (TRAM) application on AUC
values of Ca21 influx kinetics in lymphocytes obtained from nine patients with recently diagnosed RA and six RA patients with established
disease. Horizontal line22median, box22interquartile range, whiskers22range. RA, rheumatoid arthritis. aMGTX and TRAM treated sam-
ples were compared with samples with no inhibitor application within lymphocytes isolated from patients with recently diagnosed RA,
P\0.05.
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